Company releases commendable annual report amidst volatile year for public health.
CAPE TOWN, SOUTH AFRICA: 19 DECEMBER 2025: Despite a challenging global funding environment and mounting pressure on South Africa’s health system, TB HIV Care (THC) delivered dignified, life-saving care at scale during the 2024–2025 reporting period, while strengthening the systems that ensure continuity of care for underserved communities, young people, and key populations across the country.
South Africa continues to grapple with intersecting epidemics of HIV, tuberculosis (TB), intimate partner violence, substance use, mental ill-health, and economic exclusion. These challenges are intensified by service disruptions, workforce shortages, and funding instability, threatening hard-won public health gains and deepening inequality. With an estimated 8 million people living with HIV and approximately 249,000 new TB cases annually, including a growing burden of drug-resistant TB, the country remains at the epicentre of the global HIV and TB epidemics. These epidemics continue to burden women, adolescent girls, young people, sex workers, and people who inject drugs (PWID) disproportionally.
Against this backdrop, THC’s 2024–2025 impact demonstrates how integrated, community-based care can directly respond to complex and overlapping public health crises. During the reporting period, THC provided HIV testing services to more than 1.15 million people, ensuring early diagnosis and linkage to care. THC supported 321,492 people on life-saving antiretroviral therapy, achieving a 95% viral load suppression rate among those monitored, one of the strongest indicators of treatment success and reduced HIV transmission. To prevent new infections, 47,286 people were initiated on pre-exposure prophylaxis (PrEP), with a strong focus on populations at heightened risk, including adolescent girls and young women.
“Impact at this scale is built on decades of institutional knowledge, strong data systems, and community-embedded teams. Even amid funding uncertainty, our focus remains unwavering: turning resources into improved people-centred healthcare and long-term public health gains”, said Prof. Harry Hausler, Chief Executive Officer of TB HIV Care.
Recognising the deadly intersection of HIV and TB, the organisation initiated 16,207 people on TB preventive treatment, while thousands more accessed TB screening and referral services. Targeted, differentiated services reached 19,623 sex workers, addressing barriers linked to stigma, violence, and criminalisation. In response to the urgent need for harm-reduction services, more than 1,200 people who inject drugs were initiated on opiate agonist therapy, critical to reducing HIV and TB transmission and improving health outcomes in a population historically excluded from mainstream care.
Beyond biomedical interventions, THC delivered mental health, psychosocial, and sex-based violence services, recognising that intimate partner violence undermines physical and mental health, increases HIV risk, and destabilises families and communities. Economic disempowerment, substance use, and mental ill-health are addressed through integrated programming that places dignity, access, and equity at the centre of care. THC’s model combines direct service delivery with skills transfer, research, workforce development, and health systems strengthening. Its programmes are embedded within public sector responses, reinforcing, rather than duplicating, government services and ensuring sustainability beyond individual funding cycles. This approach is particularly critical in districts where HIV, TB, sex-based violence, substance use, and mental health burdens overlap, and where national averages mask localised crises.
“Good governance is public health infrastructure,” said Dr. Memory Muturiki, Chairperson of the Board. “Our responsibility is to safeguard resilience, accountability, and sustainability so that communities are never left without care. This year’s performance underscores the value of disciplined governance and diversified partnerships.”
As THC approaches nearly a century of service, the organisation continues to evolve its funding and delivery models and innovating to meet emerging public health needs. In a time of uncertainty, THC remains a cornerstone of South Africa’s public health response, proving that integrated, people-centred care can deliver impact at scale while safeguarding dignity and hope for future generations.
Access:
Issued by:
- Aziel Gangerdine
- TB HIV Care, Spokesperson
- E-mail: aziel@tbhivcare.org
- Cell: +27 (0) 66 545 6053
ENDS.
TB HIV Care
TB HIV Care is a registered non-profit company (NPC) that puts integrated care at the heart of responding to TB, HIV, and other major diseases. We work to prevent, find and treat TB and HIV in South Africa as well as targeting our interventions to address the needs of populations most at risk, including communities in the Eastern Cape and Western Cape, adolescent girls and young women in KwaZulu-Natal, inmates in correctional centres, sex workers and people who inject drugs.
